Platelet Activation in Chronic Inflammatory Skin Diseases

Status

UNKNOWN

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT01759693

Enrollment

Registered

2013-01-03

Start date

2013-02-28

Completion date

2013-10-31

Last updated

2013-01-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Atopic Dermatitis, Urticaria

Keywords

Platelet activation

Brief summary

Platelets are blood cells that are important in coagulation of the blood. These cells have recently been shown to play a role in a number of other biologic processes, for example inflammation. In this study the investigators will determine the extent of platelet activation in people suffering from common chronic skin inflammation-urticaria and allergic dermatitis.

Interventions

PROCEDUREBlood sampling

Blood sampling

Study design

Observational model

CASE_CONTROL

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to 75 Years

Healthy volunteers

Yes

Inclusion criteria

Urticaria or atopic dermatitis -

Exclusion criteria

Lack of informed consent \-

Design outcomes

Primary

Measure	Time frame	Description
Platelet activation	6 months	Platelet function will be assessed at enrollment

Secondary

Measure	Time frame	Description
Mean platelet volume	6 months	Mean platelet volume will be assessed at enrollment

Countries

Israel

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026